Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors associated with similar dementia risk in older adults
1. In this target trial emulation, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) did not significantly affect the risk of dementia ...